LEPONEX

This brand name is authorized in Austria, Brazil, Croatia, Cyprus, Ecuador, Estonia, Finland, France, Germany, Israel, Italy, Lithuania, Mexico, Netherlands, Nigeria, Poland, Romania, South Africa, Spain, Tunisia, Turkey.

Active ingredients

The drug LEPONEX contains one active pharmaceutical ingredient (API):

1
UNII J60AR2IKIC - CLOZAPINE
 

Clozapine has been shown to be an antipsychotic agent that is different from classic antipsychotics. Clozapine has potent anti-alpha-adrenergic, anticholinergic, antihistaminic, and arousal-reaction-inhibiting effects. It has also been shown to possess antiserotoninergic properties.

 
Read more about Clozapine

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
N05AH02 Clozapine N Nervous system → N05 Psycholeptics → N05A Antipsychotics → N05AH Diazepines, oxazepines and thiazepines
Discover more medicines within N05AH02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
BR Câmara de Regulação do Mercado de Medicamentos 541518080007117, 541518080007217
DE Bundesinstitut für Arzneimittel und Medizinprodukte 00071419, 01328642, 01682177, 02855102, 02855154, 03500708, 03730874, 06485406, 08757027, 08757056, 12452078
EC Agencia Nacional de Regulación, Control y Vigilancia Sanitaria 258-MEE-0414
EE Ravimiamet 1004724, 1004768, 1820180
ES Centro de información online de medicamentos de la AEMPS 59547, 59548
FI Lääkealan turvallisuus- ja kehittämiskeskus 030627, 030635, 374918, 453522, 538598
FR Base de données publique des médicaments 62552920, 67513540
HR Agencija za lijekove i medicinske proizvode HR-H-154629710, HR-H-580979278
IL מִשְׂרַד הַבְּרִיאוּת 3300, 3301
IT Agenzia del Farmaco 028824035, 028824047
LT Valstybinė vaistų kontrolės tarnyba 1001176, 1001177, 1082645, 1085682, 1085685, 1090853
MX Comisión Federal para la Protección contra Riesgos Sanitarios 008M94
NG Registered Drug Product Database 04-1597, 04-7416
Switch country to Nigeria in order to find specific presentations of LEPONEX
NL Z-Index G-Standaard, PRK 25429, 25437
PL Rejestru Produktów Leczniczych 100037187, 100212816
RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale W68785001, W68785002, W68786001, W68786002
TN Direction de la Pharmacie et du Médicament 10283071, 10283072, 21453011, 21453012
TR İlaç ve Tıbbi Cihaz Kurumu 8698856010650, 8698856010667
ZA Health Products Regulatory Authority F/2.6/69, F/2.6/70, F/2.6/71

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.